Wednesday, August 20, 2008 Free Registration Log-in to View Profiles
Empire Relations Group is a Premier Investor Relations Organization representing publicly-traded companies in their communications programs with existing shareholders and potential investors.
investments
OTCBB
OTCBB
Pressroom 
 
 Archived
 
 Non-Public Companies
 Consumer
 Energy, Environment & Natural Resources
 Financials
 Healthcare/BioTech
 Industrials
 IT & Computers
 Materials
 Telecommunications
 Utilities
 
 Public Companies
 Consumer
 Energy, Environment & Natural Resources
 Financials
 Healthcare/BioTech
 Industrials
 IT & Computers
 Materials
 Telecommunications
 Utilities
Search


Non-Public Companies : Healthcare/BioTech


Pharmacy Benefits Industry Consolidation Pushes Plan Sponsors to Seek More Choices and Flexibility in PBM Contracts

Apr 3, 2008 - 3:36:01 PM

News Source MARKET WIRE

Email this article
 Printer friendly page
ST. PAUL, MN -- (MARKET WIRE) -- 04/03/08 -- As CVS Caremark celebrates the firstanniversary of the merger that brought together retail pharmacy giant CVSCorp. and pharmacy benefit manager Caremark Rx, others in the pharmacybenefits industry are taking time to reflect on the significance of thetrend toward consolidation.

Many employers and drug plan sponsors wonder if industry consolidationswill result in a decrease in choices and competition in the marketplace --or whether it could have a positive impact on their bottom lines.

"These changes in the industry and the structures of the major serviceproviders should make plan sponsors really sit up and pay attention to whatimpact consolidation could have on their benefit packages and theirfinancial responsibilities," said Brian Bullock, president and CEO of TheBurchfield Group, a consulting firm that helps employers and other plansponsors control the costs of providing prescription drug benefits. "Theindustry is never going to stop changing, so plan sponsors need tounderstand the big picture. Are you offering the most effective benefitspackage you can, and what language in your PBM contract might cause troubledown the road?"

Plan sponsors need to understand what their PBM contracts say in terms ofpharmacy access and exclusivity, which are commonly affected by corporateconsolidation, Bullock said. It's also important to avoid particularlylong-term agreements, especially considering potential changes in pricingbenchmarks as well as structural changes resulting from consolidation.

"Consolidation is certainly not all bad for plan sponsors," said KentWangsness, vice president at The Burchfield Group. "It can open doors tonew services and cost savings that benefit the consumer and the payer. Butas always, the devil is in the details. Not knowing the ins and outs ofyour PBM contract is the one sure way to run into trouble."

To learn more about how industry consolidation might affect a plansponsor's bottom line, listen to the most recent installment of thePharmacy Benefits Podcast. The free audio program, available atwww.burchfieldgroup.com, features a discussion between Bullock andWangsness, both pharmacists who now consult for plan sponsors, onconsolidation trends and the impact of reduced competition. Bullock alsoinvites employers and other plan sponsors to contact The Burchfield Groupby sending an e-mail to info@burchfieldgroup.com or by calling1-800-778-1359.

About The Burchfield Group

The Burchfield Group is a pharmacy benefit management consultancy based inSt. Paul, Minn. The Burchfield Group brings innovative perspectives tomanaging pharmacy benefits, helping plan sponsors evaluate and selectpharmacy benefit management (PBM) vendors, designing pharmacy benefitplans, monitoring plan and PBM performance, and auditing results. Theirstaff of experts has a vast knowledge of the PBM industry, includinginsight into drug manufacturers' influences, mail service profits, andretail network margins. (www.burchfieldgroup.com)

Add to Digg Bookmark with del.icio.us Add to Newsvine

Contact:
Michael Keliher
651-695-0174 - office
651-324-0213 - cell
mkeliher@providentpartners.net



Top of Page | Main News Index | EmpireRelations.com Home Page EmpireRelations.com Selected Clients News

Come see our services. Copr. © 2005 Empire Relations Group, Inc.

Healthcare/BioTech
Latest Headlines
Qualia Clinical Services Strengthens Financial Team
Boston Medical Center Uses Envox 7 to Pioneer a New Healthcare Delivery Model
NCSBN Inducted Its Second Group of Fellows of the NCSBN Regulatory Excellence Institute on Aug. 6, 2008, During Its Annual Meeting and Delegate Assembly
Live at Millennium Monument Park -- 2008 Olympic Athletes: Bringing a New Vision to Competition
Wolf Greenfield Wins Three More Years of Patent Protection for Shire Pharmaceuticals' ELAPRASE
New Study Finds Parents Embrace Alternative Treatments for Children's Asthma
Cutting Edge Information's Research Shows Market for Breast Cancer Drugs to Top $40 Billion by 2012
SPEEDEL SHAREHOLDERS ELECT FOUR NOVARTIS OFFICERS AS NEW MEMBERS TO THE BOARD OF DIRECTORS
Government of Canada Contributes $18-Million in Support of Red Cross Relief Efforts in China and Myanmar
TOPIGEN Pharmaceuticals Appoints Mark Parry-Billings, Ph.D., as Chief Executive Officer